U.S. Construction Stock News

NYSE:DIS
NYSE:DISEntertainment

Walt Disney (DIS) After Earnings Is The Ecosystem Story Still Pointing To Fair Value

How the latest earnings reset expectations for Walt Disney stock Walt Disney (DIS) just posted its third quarter results, giving you a fresh snapshot of how the business is balancing growth in key segments with pressure on profitability and the stock’s longer term performance. For the quarter ended June 27, 2026, revenue came in at US$25.25b compared with US$23.65b a year earlier, while net income declined to US$2.64b from US$5.26b. Earnings per share from continuing operations roughly halved...
NasdaqGS:AKAM
NasdaqGS:AKAMIT

Is Akamai Technologies (AKAM) Undervalued Following Its Q2 Beat And $600 Million Cloud Deal?

Akamai Technologies (AKAM) has become a talking point after Q2 2026 results that topped expectations, anchored by a new multi year US$600 million cloud infrastructure deal and a growing focus on enterprise AI security. See our latest analysis for Akamai Technologies. Despite the earnings beat and new contracts, Akamai Technologies has seen its share price fall 21.34% over the past 90 days and 6.77% over the past 30 days, even as the year-to-date share price return is 38.25% and the 1-year...
NasdaqGS:HTO
NasdaqGS:HTOWater Utilities

H2O America (HTO) Dividend Update Keeps Fair Value In Focus

Why H2O America’s latest dividend matters for income-focused investors H2O America (HTO) recently declared a quarterly dividend of $0.44 per share, with an ex-dividend date of 10 August 2026 and payment scheduled for 1 September 2026. This payout continues a dividend record that has seen yearly increases since 1969. The company supports this policy with what appears to be solid profitability and a payout ratio that leaves room for business needs and shareholder returns. See our latest...
NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

Comcast (CMCSA) Launches First International Carrier Partnership For API Driven Connectivity

Comcast (NasdaqGS:CMCSA) Comcast Business announced a collaboration with Colt Technology Services to automate and simplify global enterprise connectivity through API driven interoperability. The partnership represents the first international carrier program for the Comcast Business Innovation Lab and focuses on programmatic access for multinational customers. Both companies plan to support seamless cross border connectivity for enterprises that want scalable, open and programmable network...
NasdaqCM:NESR
NasdaqCM:NESREnergy Services

3 Energy Stocks Tied To Oil Prices And Long Term Contracts

Energy stocks are back in focus as investors watch the July U.S. CPI report, oil price swings around the Strait of Hormuz, and shifting expectations for interest rates and inflation. This mix of forces is already testing large, established players. For investors, that creates a window where strong or weaker positioning can become clearer. This article walks through three energy sector stocks that appear positively exposed to the latest news. The stocks covered below are just a starting...
NYSE:W
NYSE:WSpecialty Retail

Why Did Wayfair (W) Move Today?

Wayfair earnings and stock reaction Wayfair (W) is back in focus after its second quarter earnings on 4 August 2026, which showed higher sales, a very small net loss, stronger adjusted EBITDA and higher free cash flow. Investors also reacted to management's expectation for continued revenue growth, comments about market share gains and plans to expand the physical retail footprint, including a new Pittsburgh store scheduled to open in 2027. See our latest analysis for Wayfair. Wayfair's share...
NYSE:NPO
NYSE:NPOMachinery

Will Strong Q2 Results and Higher 2026 Guidance Change Enpro's (NPO) Advanced-Tech Narrative?

Enpro Inc. reported its second-quarter 2026 results, with sales rising to US$338.8 million and net income reaching US$27.1 million, while also affirming a quarterly dividend of US$0.32 per share payable in September 2026. The company also raised its 2026 revenue growth outlook to a range of 14% to 16%, indicating increased confidence relative to its prior expectations. Now we’ll assess how Enpro’s higher 2026 revenue growth guidance may reshape the existing investment narrative built on...
NYSE:MMM
NYSE:MMMIndustrials

Should Explosion-Related Safety Verdicts And Litigation Exposure Require Action From 3M (MMM) Investors?

A Harris County jury recently ordered 3M to pay US$61.5 million to Houston homeowners for its role in the 2020 Watson Grinding & Manufacturing explosion, after finding failures in servicing the facility’s gas detection and alarm systems contributed to the disaster. This third successful bellwether trial in the multi-district litigation highlights how 3M’s service practices for safety systems can translate into substantial legal liabilities and community impact. We’ll now examine how this...
NYSE:U
NYSE:USoftware

Atlassian Stock And 2 Cash Flow Picks Worth A Closer Look

Global bond yields have been climbing as inflation worries keep central banks cautious on interest rates. That backdrop has drawn more attention to cash flows and valuations, since higher yields can pressure richly priced stocks. The Undervalued Stocks Based On Cash Flows screener focuses on companies where discounted cash flow estimates point to a gap between price and fair value. This article highlights three stocks that currently stand out on that list. The stocks covered below are just a...
NasdaqGS:WYNN
NasdaqGS:WYNNHospitality

Is Wynn Resorts (WYNN) Cheap As Strong Earnings And A Dividend Lift Confidence?

Wynn Resorts (WYNN) is back in focus after reporting second quarter 2026 results, issuing a cash dividend, and updating investors on its ongoing share repurchase activity announced earlier. See our latest analysis for Wynn Resorts. The earnings beat, dividend declaration, and progress on buybacks have put Wynn Resorts back on investors’ radar, even as the share price sits at $102.50 with a year to date share price return that is down 16.37% and a one year total shareholder return that is down...
NYSE:FNF
NYSE:FNFInsurance

Higher Bond Yields Are Putting These U.S. Insurance Stocks In Focus

With U.S. bond yields at multi year highs, inflation still above the Fed’s target, and markets second guessing what comes next under Kevin Warsh, interest rate sensitivity is firmly back in focus. That mix creates both risk and potential opportunity for investors watching how insurance stocks react to higher real yields. This article explains how the news relates to insurers and highlights 3 stocks from the screener to watch closely. The three insurers covered next are just a sample from this...
NYSE:XYL
NYSE:XYLMachinery

How Investors May Respond To Xylem (XYL) Lowering 2026 Outlook While Accelerating Buybacks And M&A

In late July and early August 2026, Xylem Inc. reported higher quarterly revenue and net income, booked US$4 million of intangible asset impairments, modestly trimmed its full-year 2026 revenue outlook to about US$9.2 billion, completed a US$1.05 billion buyback, and filed an omnibus shelf registration for multiple securities. Alongside this mixed update, management reiterated its intention to deploy about US$1 billion per year toward accretive acquisitions, signaling continued emphasis on...
NYSE:AAT
NYSE:AATREITs

American Assets Trust (AAT) Reports Q2 2026 Earnings, Is The 4% Undervaluation Enough?

American Assets Trust (AAT) has released its second quarter 2026 earnings, giving investors fresh detail on sales, revenue and earnings per share as of June 30. The update also covers performance for the first half of 2026. See our latest analysis for American Assets Trust. Despite the recent earnings update, American Assets Trust’s share price has eased, with a 7 day share price return of 5.57% and a 30 day share price return of 10.27%. However, the year to date share price return of 20.02%...
NYSE:VTR
NYSE:VTRHealth Care REITs

Ventas (VTR) Could Be 7% Below Fair Value After Q2 Earnings Update

Why Ventas Stock Is Back in Focus After Q2 Earnings Ventas (VTR) drew fresh attention after releasing second quarter 2026 results, along with a higher senior housing investment target and a modestly raised full year earnings outlook, which together shaped recent investor sentiment. See our latest analysis for Ventas. Against this backdrop, Ventas shares closed at US$91.95 and have delivered an 18.91% year to date share price return. The 1 year total shareholder return of 37.65% and 3 year...
NYSE:HSY
NYSE:HSYFood

Hershey (HSY) Could Be 39% Undervalued After Kisses Recall კითხვ

What the Kisses recall could mean for Hershey stock The latest focus on Hershey (HSY) comes after a national recall of Kisses Creamy Milk Chocolate products due to undeclared almond, a tree nut allergen that raises questions around brand risk and investor perception. For investors, product quality incidents like this matter because they can influence costs, consumer trust and regulatory attention. The key task is working out how a recall of a single product range fits into the wider Hershey...
NYSE:AVTR
NYSE:AVTRLife Sciences

Margin Squeeze And Buybacks Might Change The Case For Investing In Avantor (AVTR)

Avantor, Inc. has reported its second-quarter and first-half 2026 results, with sales inching up to US$1,692.3 million and US$3,273.7 million respectively, while net income fell to US$38.1 million for the quarter and US$81.4 million for the half year compared with the same periods in 2025. Despite this earnings squeeze, Avantor’s previously announced share repurchase program remains largely executed at 6,629,063 shares bought back for US$74.97 million, offering a contrasting signal of...
NasdaqGS:ADTN
NasdaqGS:ADTNCommunications

3 Technology Hardware Stocks Retail Investors Are Watching As Chip Costs Rise

Rising chipflation and tight supply in servers and storage hardware are pulling future demand into today, as enterprises rush to lock in equipment before costs bite harder. That rush can create pricing power and margin pressure at the same time, which is exactly where opportunities often appear first. This article explains how the news affects three specific hardware stocks and why their exposure to this story matters for your portfolio watchlist. The stocks covered below are just a starting...
NYSE:EVR
NYSE:EVRCapital Markets

Evercore (EVR) Senior Hire And Earnings Put Fair Value Back In Focus

Executive hire and recent results put Evercore in focus Evercore (EVR) has drawn fresh attention after appointing Dylan Tornay as senior managing director in its equity capital markets group, alongside recent quarterly earnings and a confirmed dividend declaration. Tornay joins from Citi with nearly 30 years of equity capital markets experience. He will focus on industrials and infrastructure, areas that may matter for investors watching how Evercore positions its advisory and capital markets...
NasdaqGS:PLUS
NasdaqGS:PLUSElectronic

The Bull Case For ePlus (PLUS) Could Change Following Mixed Q1 FY27 Results And Capital Return Plans

In early August 2026, ePlus Inc. reported Q1 FY27 results showing revenue of US$649.11 million and lower net income of US$30.28 million year on year, while reiterating mid-single-digit growth guidance for fiscal 2027 and declaring a quarterly dividend of US$0.27 per share. Management also highlighted that a strong balance sheet is allowing ePlus to keep funding organic growth, evaluate acquisitions, and return cash to shareholders through dividends and share repurchases, offering a mixed...
NasdaqGS:DHC
NasdaqGS:DHCHealth Care REITs

Improved Losses Amid Weaker Revenue Might Change The Case For Investing In Diversified Healthcare Trust (DHC)

Diversified Healthcare Trust recently reported past second-quarter 2026 results, with sales of US$47.47 million and revenue of US$365.39 million, alongside a net loss of US$37.42 million and basic loss per share from continuing operations of US$0.16. Despite lower sales and revenue versus a year earlier, the trust reduced its net loss and loss per share, indicating that expense controls and operational adjustments are limiting the impact of softer top-line performance. We’ll now examine how...
NYSE:SXI
NYSE:SXIMachinery

Standex International (SXI) Earnings And FY27 Outlook Put Valuation Back In Focus

Standex International (SXI) has moved into focus after reporting higher quarterly and full year sales and net income, alongside guidance that points to further organic growth and an expanded new product pipeline in fiscal 2027. See our latest analysis for Standex International. Against this backdrop, Standex International's share price has climbed strongly, with a 90 day share price return of 28.68% and a year to date share price return of 45.93%. The 1 year total shareholder return of 75.26%...
NYSE:TDY
NYSE:TDYElectronic

Is Teledyne Technologies (TDY) Fairly Valued As It Buys Varex Imaging?

Teledyne Technologies (TDY) has agreed to acquire Varex Imaging in an all cash transaction valued at about US$1.1b, offering US$18.90 per Varex share. This move adds oncology focused X-ray detectors to Teledyne's portfolio. See our latest analysis for Teledyne Technologies. At a share price of US$690.25, Teledyne Technologies has posted a 30 day share price return of 8.77% and a year to date share price return of 33.06%. The 3 year total shareholder return of 71.49% points to sustained...
NasdaqGM:ORKA
NasdaqGM:ORKABiotechs

Oruka Therapeutics (ORKA) On Its Earnings Miss And Whether The Valuation Still Holds

Oruka Therapeutics (ORKA) drew investor attention on August 10 after reporting second quarter 2026 results that showed a wider loss per share than consensus expectations as the company continues funding its clinical pipeline. See our latest analysis for Oruka Therapeutics. The earnings miss has arrived after a strong run in Oruka Therapeutics' stock, with the latest share price at $105.14 and a year to date share price return of 271.91%. Over the past year, total shareholder return is very...
NasdaqGS:TSHA
NasdaqGS:TSHABiotechs

Taysha Gene Therapies (TSHA) Is Up 10.2% After Securing Long-Term TSHA-102 Manufacturing Capacity

Taysha Gene Therapies recently announced a commercial supply agreement under which Catalent will serve as the primary commercial manufacturer of TSHA-102, its investigational Rett syndrome gene therapy, at Catalent’s FDA-licensed facility in Harmans, Maryland, securing long-term GMP capacity to support potential U.S. launch and future demand. This move effectively locks in a scalable manufacturing backbone for TSHA-102, signaling that Taysha is preparing its operations for possible...